You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日總結》恆指升378點 恆生科指漲逾3% 藥明生物彈一成
市場憧憬中概股披露審計訊息方面取得進展,小米(01810.HK)繼阿裏巴巴(09988.HK)後提出股份回購,科網股帶動港股早市造好。恆指高開199點後反覆上升,曾升534點見22,423點,中午前升幅收窄,半日升378或1.73%,報22,267點;國指升138點或1.84%,報7,677點;恆生科技指數升150點或3.23%,報4,803點。大市半日成交總額1,016.14億元,滬、深港通南下交易半日分別淨流入21.2億及22.06億元人民幣。 小米去年經調整淨利潤升69.5%勝預期,將斥最多100億元回購股份,股價升6.1%報15.06元。阿裏巴巴增加股份回購消息續推動股價,早市升7.1%報118元。閱文(00772.HK)扭虧去年純利彔彔18.47億人民幣,股價升9.9%。 其他科技股方面,騰訊(00700.HK)升2.7%報398.4元,美團(03690.HK)、百度(09888.HK)、網易(09999.HK)、快手(01024.HK)及金蝶(00268.HK)各升4.1%至5.5%,嗶哩嗶哩(09626.HK)升10.2%報229.2元,平安好醫生(01833.HK)升7.6%,微盟(02013.HK)彈升18%。舜宇(02382.HK)去年純利升2.4%,半日股價升0.3%。 消費股普遍造好,海底撈(06862.HK)、百勝中國(09987.HK)、JS環球生活(01691.HK)、九毛九(09922.HK)及泡泡瑪特(09992.HK)各升5%至6.6%,呷哺呷哺(00520.HK)、頤海(01579.HK)及貓眼娛樂(01896.HK)各升3.9%。體育用品股安踏(02020.HK)去年多賺五成,市場關注疫情影響今年業績,股價跌2%報103.3元。 美股特斯拉(TSLA.US)股價急彈,本港上市車股造好,蔚來(09866.HK)及小鵬(09868.HK)各升7.5%及4.5%。吉利(00175.HK)公佈業績前升4.4%報12.3元,比亞迪(01211.HK)升2.9%。國家發改委發佈《氫能產業發展中長期規劃》,相關概念股受刺激。京城機電(00187.HK)及東嶽(00189.HK)各升20%及14.8%,濰柴(02338.HK)及中集安瑞科(03899.HK)各升4.3%及7%。 醫藥股藥明生物(02269.HK)去年純利升1倍,早市股價升10.2%報64.3元,藥明康德(02359.HK)升8.1%。信達生物(01801.HK)升8%,石藥(01093.HK)、中生製藥(01177.HK)及石四藥(02005.HK)各升3.9%至4.4%。 匯控(00005.HK)升2.1%報53.45元,港交所(00388.HK)及友邦(01299.HK)各升1.6%及1.2%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account